Evaluation of the Manifestation of Patient Aggresivity in an Emergency Department
NCT ID: NCT02116439
Last Updated: 2025-12-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
30 participants
OBSERVATIONAL
2014-04-02
2014-04-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of a Mediator for Patient Intake in Emergency Departments
NCT03139110
Study Of the Nitrous Oxide Perception in Health Students
NCT04095494
Physician-nurse Team to Reduce Emergency Department (ED) Overcrowding
NCT01219868
Impact on Mortality of Hospitalisation of a Patient in a Hospital Bed That Does Not Correspond to His Needs After a Visit to the Emergency Department
NCT07347847
the Observance of Emergency Exit Treatments During the Stay of Care at the Exit of Reims Emergencies
NCT03836534
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Observation periods are randomly selected over a period of 1 year, and stratified for time of day (morning, afternoon, evening), day of the week and month.
The secondary objectives of the observation phase are to identify factors associated with the average number of violent events per work period (number of patients attending the emergency department, time of staff debriefing during shift change, time of day, week or weekend, individual patient characteristics (gender, age, patient or accompanying a patient, waiting time from arrival in the emergency room to emergency consultation, reason for consultation), characteristics of victims of violence, characteristics of the health care team ...)
The anticipated total number of violent events is unknown at the beginning of the study; we indicated '50' as a guess.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
ECOLOGIC_OR_COMMUNITY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Violent events
People in this group were observed to manifest violence.
No interventions assigned to this group
Victims
People in this group are the victims of the other group.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The victims of the above-mentioned violence will also be observed and interviewed
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Nīmes
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Muriel Chazel
Role: PRINCIPAL_INVESTIGATOR
CHRU de Nîmes - Hôpital Universitaire Carémeau
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHRU de Nîmes - Hôpital Universitaire Carémeau
Nîmes, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Chazel M, Alonso S, Price J, Kabani S, Demattei C, Fabbro-Peray P. Violence against nurses in the emergency department: an observational study. BMJ Open. 2023 Apr 4;13(4):e067354. doi: 10.1136/bmjopen-2022-067354.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1739572 v 0
Identifier Type: OTHER
Identifier Source: secondary_id
PHRIP/2013/MC-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.